STRS Ohio’s Praxis Precision Medicines PRAX Stock Holding History

STRS Ohio’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.16M	Buy	3,600 +400	+13%	+$124K	﹤0.01%	676
2025 Q4	$943K	Buy	+3,200	New	+$596K	﹤0.01%	720
2021 Q3	–	Sell	-180	Closed	-$49K	–	2305
2021 Q2	$49K	Hold	180	–	–	﹤0.01%	2112
2021 Q1	$88K	Hold	180	–	–	﹤0.01%	1966
2020 Q4	$148K	Buy	+180	New	+$105K	﹤0.01%	1810

Other funds holding PRAX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

STRS Ohio's PRAX Position: Q1 2026 in Review

STRS Ohio increased its Praxis Precision Medicines (PRAX) stake by 13% in Q1 2026, buying an estimated $124K and bringing the position to 3,600 shares worth $1.16M. The position accounts for ﹤0.01% of the portfolio, ranked #676.

STRS Ohio first reported a position in PRAX in Q4 2020 and has held it in 5 quarters since. 289 funds tracked by Wall St. Rank hold PRAX as of Q1 2026.

STRS Ohio held 3,600 shares of Praxis Precision Medicines worth $1.16M as of Q1 2026.
STRS Ohio bought 400 Praxis Precision Medicines shares in Q1 2026, an estimated $124K.
Praxis Precision Medicines made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #676 holding.
STRS Ohio first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 5 quarters since.
289 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.